Related references
Note: Only part of the references are listed.Six-Minute Walk Distance After Critical Illness: A Systematic Review and Meta-Analysis
Selina M. Parry et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2021)
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)
Chaolin Huang et al.
LANCET (2021)
Attributes and predictors of long COVID
Carole H. Sudre et al.
NATURE MEDICINE (2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
Ryan S. Thwaites et al.
SCIENCE IMMUNOLOGY (2021)
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Rachael A. Evans et al.
LANCET RESPIRATORY MEDICINE (2021)
Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study
Cesar Fernandez-de-las-Penas et al.
LUNG (2021)
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
Annemarie Docherty et al.
LANCET RESPIRATORY MEDICINE (2021)
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang et al.
LANCET (2021)
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Evdoxia Kyriazopoulou et al.
NATURE MEDICINE (2021)
Long COVID in a prospective cohort of home-isolated patients
Bjorn Blomberg et al.
NATURE MEDICINE (2021)
Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19)
Paolo Boscolo-Rizzo et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)
Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics
Krzysztof Laudanski et al.
FRONTIERS IN IMMUNOLOGY (2021)
Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals
Liina Tserel et al.
FRONTIERS IN IMMUNOLOGY (2021)
Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge
Modesto M. Maestre-Muniz et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Treatment Guidelines for PTSD: A Systematic Review
Alicia Martin et al.
JOURNAL OF CLINICAL MEDICINE (2021)
COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force
Martijn A. Spruit et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19
Weihui Fu et al.
ECLINICALMEDICINE (2020)
Minimum important difference of the incremental shuttle walk test distance in patients with COPD
Rachael A. Evans et al.
THORAX (2019)
CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis
Tessa Dhaeze et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Validity, responsiveness and minimum clinically important difference of the incremental shuttle walk in idiopathic pulmonary fibrosis: a prospective study
Claire M. Nolan et al.
THORAX (2018)
Persistent inflammation and recovery after intensive care: A systematic review
David M. Griffith et al.
JOURNAL OF CRITICAL CARE (2016)
Measurement Properties of the Incremental Shuttle Walk Test A Systematic Review
Veronica F. Parreira et al.
CHEST (2014)
Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients
Stefan Hettwer et al.
EXPERIMENTAL GERONTOLOGY (2013)
Quality of life after acute respiratory distress syndrome: a meta-analysis
David W. Dowdy et al.
INTENSIVE CARE MEDICINE (2006)